Article Text

Treatment of Haart-Associated Metabolic Changes in Patients with HIV Infection

Statistics from

Purpose: The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Heart, Lung and Blood Institute (NHLBI) seek applications to develop and test strategies for treating the metabolic complications associated with anti-retroviral drug therapy in patients with HIV infection. In recent years, the advent of highly active anti-retroviral therapy (HAART) has dramatically improved the survival of patients infected with HIV. Despite the benefits of the new anti-retroviral therapies, HAART has been associated with a variety of metabolic complications - including dyslipidemia, insulin resistance and abnormal distribution of body fat (lipodystrophy) - …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.